John H. Eldridge
15Patents
10h-index
25Co-inventors
72Inventor score
Filing activity: Mar 18, 1988 → Feb 27, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5075109A | Method of potentiating an immune response | Emerging Cross-Sectional Technologies | 413 | Expired |
| US5820883A | Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release | Emerging Cross-Sectional Technologies | 182 | Expired |
| US5942252A | Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissues and controlling their release | Emerging Cross-Sectional Technologies | 158 | Expired |
| US5853763A | Method for delivering bioactive agents into and through the mucosally-associated lymphoid tissue and controlling their release | Emerging Cross-Sectional Technologies | 150 | Expired |
| US5814344A | Method for delivering bioactive agents into and through the mucosally associated lymphoid tissues and controlling their release | Emerging Cross-Sectional Technologies | 143 | Expired |
| US5811128A | Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor | Emerging Cross-Sectional Technologies | 112 | Expired |
| US6306404A | Adjuvant and vaccine compositions containing monophosphoryl lipid A | Emerging Cross-Sectional Technologies | 74 | Expired |
| US7384640B1 | Mutant cholera holotoxin as an adjuvant | Chemistry; Metallurgy | 42 | Expired |
| US6024983A | Composition for delivering bioactive agents for immune response and its preparation | Emerging Cross-Sectional Technologies | 31 | Expired |
| US6488936B1 | Immunogenic composition of interleukin-12 (IL-12), alum, herpes simplex viral (HSV) antigen, and method thereof | Chemistry; Metallurgy | 26 | Expired |
| US6635261B2 | Adjuvant and vaccine compositions containing monophosphoryl lipid A | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6709658B1 | Pneumococcal vaccines formulated with interleukin-12 | Human Necessities | 3 | Expired |
| US6841160B2 | Meningococcal vaccines formulated with interleukin-12 | Human Necessities | 3 | Expired |
| US8623382B2 | Immunogenic compositions for inducing an immune response to HIV | Chemistry; Metallurgy | 1 | Active |
| US9932564B2 | Recombinant isfahan viral vectors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.